Averto Medical Secures FDA Breakthrough Device Status for ColoSeal™ Intraluminal Colonic Diversion System
Averto Medical, a clinical-stage medical device company pioneering minimally invasive gastrointestinal care, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its ColoSeal™ Intraluminal Colonic Diversion (ICD) System. This designation underscores the potential of ColoSeal™ to significantly improve outcomes for patients undergoing colorectal
